CMV 2021
2nd Congress on Congenital CMV
21 – 22 OCTOBER 2021
Rome, Italy
Scientific Goal
The most prevalent congenital infection and the first cause of non genetic hearing loss continues to be largely ignored or misunderstood outside expert circles. We invite all care providers to attend this meeting to meet the experts and improve their practice for a better outcome.
Congress Presidents
Yves Ville, France
Professor of Gynecology-Obstetrics, Faculty of Medicine of René Descartes University
Head of the Obstetrics and Fetal Medicine Department
CPDPN coordinator of Necker Children’s Hospital
Efraim Bilavsky, Israel
Senior physician in the pediatric department
A specialist in infectious diseases,
Schneider Children’s Medical Center
Main Topics of CMV 2021
- The risks in pregnancy are well defined
- Screening and diagnostic tools are efficient, and quality control is effective
- Primary prevention is part of preconceptional medicine
- Vaccine technology has been revolutionized by the COVID pandemic
- Diagnosis is as reliable prenatally and postnatally
- Secondary and tertiary prevention are efficient and should be widely implemented
- Postnatal care has been simplified and rationalized
- Sensorineural hearing loss is not a fatality
- Are there any late complications other than hearing impairment is asymptomatic children?
- Sensorineural hearing loss is not a fatality
- Hearing rehabilitation in cCMV children with unilateral hearing loss
- Is there an association between CMV infections and ADD/Autism/Schizophrenia?
- Brain imaging for children with cCMV – Ultrasound or MRI?
- Universal screening for cCMV
- Early diagnosis of cCMV using Chorionic villus sampling
- Vestibular problems in symptomatic and asymptomatic cCMV
- What can we offer to asymptomatic children with late onset hearing loss?
JOIN THE CONGRESS!
Media Partners
Keep Yourself
Posted!
Subscribe to the Congress Newsletter and get your 5% discount code!